article · Zagazig University Medical Journal
Background: The occurrence of no-reflow in patients with STEMI means inadequate myocardial reperfusion despite patent coronary arteries . Electrocardiogram (ECG) is a widely available non-invasive diagnostic tool in daily practice that is easy to use. So our study aimed to evaluate the corrected value of T wave peak interval to end terminal (cTPE) and corrected QT and assess the ratio of cTPE\ c QT in predicting no-reflow. Methods: A total of 120 patients who fulfilled inclusion and exclusion criteria were subjected to 12 leads surface ECG, TPE interval was measured from the peak of the T wave to the end terminal of the T wave tangent to the baseline in the leads the least ST changes (defined as less than <0.055 mV from the isoelectric line. QT interval was assessed from the onset of the QRS complex to the T wave end, other clinical and angiographic data were compared in successful and no-reflow groups. Results: The population study was divided into no-reflow group I accounting for 33.3% and successful reperfusion group II accounting for 66.7%. Admission time cTPE\ cQT was prolonged in group I 0.281±1.94 compared to 0.192±1.07 in group II. Multivariate analysis showed that admission time from symptoms onset to hospital admission (0.017), followed by Hs-troponin peak value pg\ml (0.007), then Admission time cTPE\ cQT (0.001) were significant predictors of impaired flow TIMI <3 . Conclusion: Admission time cTPE\ cQT at a cut-off value ≥ 0.243 ms could accurately predict impaired flow TIMI <3 post PCI.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/zumj.2024.291366.3407
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.